Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis

NCT05591755 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Conjunctivitis

Interventions

DRUG: Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
DRUG: Ketotifen fumarate ophthalmic solution 0.035%
DRUG: Brimonidine tartrate ophthalmic solution 0.025%
DRUG: Experimental: Vehicle ophthalmic solution

Sponsor

Bausch & Lomb Incorporated